S
SHANDONG KEXING BIO PRODUCTS CO.,LTD.
常乐康由酪酸梭菌芽孢杆菌和婴儿型双歧杆菌两肠道优势原籍菌联合而成，相互促生，协同增效，具有免疫调节作用，有着广泛的临床应用及循证支持。
Country/Area ：China
Company Email ：info@sinovac.com
Industry ：BiotechnologyEnergy, Utilities & Waste TreatmentEnergy, Utilities & Waste Treatment General
Company address ：China, Jinan, No.2666, Chuangye Road
Company website ：*****
Company phone ：+86 4008889496
Established ：1997
Company Revenue ：$3,579,000
Number of employees ：<25
SIC Code ：28283
NAICS Code ：32325
Main Products ：英夫利西单抗公司公告动物疫苗合成生物全球研发中心利拉鲁肽版权所有鲁ICP备19058750号-1人粒细胞刺激因子 预防和治疗中性粒细胞减少症的临床一线用药 白特喜临床应用20余年，有着广泛的循证应用，是肿瘤放化疗后的升白细胞和改善骨髓造血功能的临床一线用药。 探索详情克癀胶囊阿达木单抗投资互动创新研发酪酸梭菌二联活菌 老幼孕产妇均可使用的独家益生菌产品 常乐康由酪酸梭菌芽孢杆菌和婴儿型双歧杆菌两肠道优势原籍菌联合而成，相互促生，协同增效，具有免疫调节作用，有着广泛的临床应用及循证支持。 探索详情质量管控人干扰素α1b 采用中国人基因克隆和表达的α1b型干扰素 国家基本药物目录、国家医保目录（乙类）品种，广谱抗病毒、抗肿瘤、免疫调节。 探索详情研发领域贝伐珠单抗行情动态恩替卡韦片公司治理人促红素 多领域治疗贫血的临床一线用药 依普定是国内首批立项研发，第一批获新药证书和正式批准文号的人促红素，首家采用预充式注射器，不含人血白蛋白，出口巴西、菲律宾、印度尼西亚等全球30多个国家。 探索详情法律声明
Company News
Kexing Biopharm Obtains the Products of Trastuzumab and Neratinib Maleate Tablets
Jun 26, 2023
Shenzhen, China--(Newsfile Corp. - June 26, 2023) - Recently, Kexing Biopharm (688136.SH) signed with Chia-Tai Tianqing (CTTQ) an exclusive cooperation agreement for overseas commercialization of Trastuzumab for Injection. As a result, it has obtained the rights to commercialize the first batch of Trastuzumab for Injection in 12 countries. Meanwhile, Kexing has also signed with Convalife Pharmaceuticals a cooperation agreement for the international commercialization of Neratinib Maleate Tablets.
Jun 26, 2023
Going Global - Kexing Biopharm Expands Global Reach at the 2023 KIHEMay 26, 2023
Shenzhen, China--(Newsfile Corp. - May 26, 2023) - Kexing Biopharm, a leading pharmaceutical company, has successfully concluded its participation at the renowned Kazakhstan International Healthcare Exhibition (KIHE) 2023, held at the Atakent International Exhibition Centre. With a sprawling exhibition area of 4551 square meters, KIHE attracted over 200 prominent pharmaceutical enterprises, solidifying its status as one of Kazakhstan's premier exhibitions.KIHE serves as a vital platform that...
May 26, 2023Kexing Biopharm's Completion of the First Dose of Its Long-Acting GC Product in Subjects in Phase 1 Clinical Study for In-Depth Layout of WBC-Stimulating Drug MarketApr 28, 2023
Shenzhen, China--(Newsfile Corp. - April 28, 2023) - Recently, Kexing Biopharm (688136.SH) has completed the first dose of its long-acting GC product, Pegylated Human Granulocyte Colony-stimulating Factor Injection (hereinafter referred to as long-acting GC) developed in China, in all enrolled subjects in the Phase I clinical study, showing favorable safety and tolerability.Synergistically Promoting Long- and Short-Acting Drugs, Effectively Accelerating R&DFor patients with malignancies, the...
Apr 28, 2023Embracing Opportunities and Shaping the Future with Kexing - Kexing Biopharm Shines at the 88th API ChinaApr 28, 2023
Qingdao, China--(Newsfile Corp. - April 27, 2023) - The 88th API China, a prestigious pharmaceutical event, took place at the Qingdao Cosmopolitan Exposition Exhibition Centre, where regional representatives from Kexing Biopharm's Overseas Marketing Division convened to participate.Established in 1968, the China International Pharmaceutical API/Intermediate/Packaging/Equipment Fair (API China) has become a professional platform dedicated to providing comprehensive solutions for the...
Apr 28, 2023Kexing Biopharm Attend the 5th Greater Bay Area Biopharmaceutical Innovators SummitMar 23, 2023
Shenzhen, China--(Newsfile Corp. - March 23, 2023) - Recently, the 5th Greater Bay Area Biopharmaceutical Innovators Summit has been held successfully in Guangzhou China. Kexing Biopharm Co., Ltd. (hereinafter referred to as "Kexing Biopharm", 688136. SH), as co-organizer, hosted the symposium -"Globalization of Biopharmaceutical, Investment, and Cooperation", inviting multiple industry veterans to discuss hot topics related to the deployment of biopharmaceuticals globalization business. Kexing.
Mar 23, 2023Web Summary
Q1: What is the address of Shandong Kexing Bio Products Co., Ltd.?
A1: The company's address is not explicitly mentioned in the provided text, but it can be found on their official website.
Q2: What products does Shandong Kexing Bio Products Co., Ltd. offer?
A2: The provided text does not specifically mention the types of products offered by the company, but it mentions that they are involved in bio-products and have a focus on research and development.
Q3: In which industry is Shandong Kexing Bio Products Co., Ltd. operating?
A3: Based on the information available, Shandong Kexing Bio Products Co., Ltd. appears to be operating in the biotechnology or pharmaceutical industry, given their focus on bio-products and research.
Q4: What services does Shandong Kexing Bio Products Co., Ltd. provide?
A4: The provided text does not explicitly mention the specific services offered by the company, but it implies that they are involved in providing solutions related to bio-products and have a focus on research and development.
Q5: How can one contact Shandong Kexing Bio Products Co., Ltd.?
A5: According to the provided text, one can contact the company through phone number 400-888-9496 or email address 0531-58258126.
Q6: What is the company's official website?
A6: The provided text does not explicitly mention the company's official website, but it mentions that their information can be found on their official website.
Q7: What is the ICP number of Shandong Kexing Bio Products Co., Ltd.?
A7: According to the provided text, the company's ICP number is 19058750å·-1.
Q8: When was the company established?
A8: The provided text does not explicitly mention when the company was established, but it mentions that they have been involved in research and development since 2018.
A1: The company's address is not explicitly mentioned in the provided text, but it can be found on their official website.
Q2: What products does Shandong Kexing Bio Products Co., Ltd. offer?
A2: The provided text does not specifically mention the types of products offered by the company, but it mentions that they are involved in bio-products and have a focus on research and development.
Q3: In which industry is Shandong Kexing Bio Products Co., Ltd. operating?
A3: Based on the information available, Shandong Kexing Bio Products Co., Ltd. appears to be operating in the biotechnology or pharmaceutical industry, given their focus on bio-products and research.
Q4: What services does Shandong Kexing Bio Products Co., Ltd. provide?
A4: The provided text does not explicitly mention the specific services offered by the company, but it implies that they are involved in providing solutions related to bio-products and have a focus on research and development.
Q5: How can one contact Shandong Kexing Bio Products Co., Ltd.?
A5: According to the provided text, one can contact the company through phone number 400-888-9496 or email address 0531-58258126.
Q6: What is the company's official website?
A6: The provided text does not explicitly mention the company's official website, but it mentions that their information can be found on their official website.
Q7: What is the ICP number of Shandong Kexing Bio Products Co., Ltd.?
A7: According to the provided text, the company's ICP number is 19058750å·-1.
Q8: When was the company established?
A8: The provided text does not explicitly mention when the company was established, but it mentions that they have been involved in research and development since 2018.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
